We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for people who commission, fund, deliver and evaluate health outreach programmes.
Overview of the UK's cell and gene therapy research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
Research investigating the shortcomings of the concept of coastal cells, and the long-term gains and losses of beach sediments around English and Welsh coastlines.
SaBTO recommendations on the donation of starting material for cell-based advanced therapies.
Official Development Assistance to arm's length bodies and FCDO-led soft power programmes for April 2018 to December 2022.
Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020
Information for parents of babies who carry the sickle cell gene.
Sets out how the UK and devolved governments propose to continue to work closely and collaboratively together on organs and non-reproductive tissues and cells policy.
The UK Stem Cell Bank Steering Committee oversees the activities of the UK Stem Cell Bank and the use of human embryonic stem cell lines in the UK.
The MHRA’s UK Stem Cell Bank is one of only two places in the world to test this technology.
Findings from research by the MHRA have been published, evaluating two different approaches to cancer therapies which harness the immune system to determine which better targets cancer cells and would reduce side effects for patients.
Japanese company launches open innovation centre at Stevenage Bioscience Catalyst (SBC) to develop Smart Cell Processing Technologies.
The UK Stem Cell Bank (UKSCB) at the National Institute for Biological Standards and Control (NIBSC) is releasing its first stem cell lines suitable for development into novel cell-based medicines to researchers wishing to bring new and innovative therapies to...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.